Key result
Posterior wall ablation added to PVI fails to improve arrhythmia-free survival in persistent AF.
Why the study?
The efficacy of left atrial posterior wall isolation for persistent AF is controversial, prompting evaluation of the efficacy and safety of a modified posterior wall ablation strategy during first-time radiofrequency catheter ablation.
Does adding modified left atrial posterior wall ablation to pulmonary vein isolation improve 12-month freedom from atrial arrhythmia in patients with persistent atrial fibrillation undergoing first-time radiofrequency catheter ablation?
RCT (n=276)
Single-blind
1:1
Yes
Does adding modified left atrial posterior wall ablation to pulmonary vein isolation improve 12-month freedom from atrial arrhythmia in patients with persistent atrial fibrillation undergoing first-time radiofrequency catheter ablation?
Routine addition of modified posterior wall ablation to pulmonary vein isolation does not improve 12-month arrhythmia-free survival in first-time ablation for persistent AF, largely due to a 65.5% acute PWI success rate.
Answers are grounded in this paper and cite their sources.
Does not support routine addition of modified posterior wall ablation to PVI in persistent AF; challenges prior inconclusive evidence on its efficacy.
AIMS: The efficacy of left atrial posterior wall isolation (PWI) for persistent atrial fibrillation (AF) is controversial. We propose a modified left atrial posterior wall ablation strategy. OBJECTIVES: To evaluate the efficacy and safety of modified posterior wall ablation in patients with persistent AF who underwent first-time radiofrequency catheter ablation. METHODS AND RESULTS: In this multicenter, single-blind randomized trial, 276 patients with persistent AF were assigned 1:1 to pulmonary vein isolation (PVI) with (BOX+) or without modified posterior wall ablation (BOX-). Seven participants withdrew, leaving 269 (BOX+, n=139; BOX-, n=130) for primary endpoint analysis. The primary endpoint was freedom from any documented atrial arrhythmia lasting > 30 seconds without antiarrhythmic drugs after a 3 -month blanking period. At 12-month follow-up, the primary endpoint occurred in 120 of 139 patients (86.3%) in the BOX+ group and 113 of 130 (86.9%) in the BOX- group (hazard ratio 1.046, 95% CI, 0.54 - 2.01; P = 0.894). The BOX+ group exhibited longer procedure time and ablation time. Acute successful PWI was achieved in 91 (65.5%) patients assigned to BOX+. In a nonprespecified, post-randomization analysis, arrhythmia-free survival was 93.4% in patients with acute successful PWI, 72.9% in those with attempted but unsuccessful PWI, and 86.9% in controls without attempted PWI (overall log-rank P=0.002). Adverse events were similar between groups. CONCLUSION: Routine addition of modified posterior wall ablation did not improve overall outcomes of first-time ablation in persistent AF. However, achieving successful PWI was associated with significantly lower recurrence.
No takes yet. Share an insight, caveat, or question.
周根清 et al. (2026) conducted an RCT in Persistent atrial fibrillation (n=276). Pulmonary vein isolation with modified posterior wall ablation (BOX+) vs. Pulmonary vein isolation without modified posterior wall ablation (BOX-) was evaluated on Freedom from any documented atrial arrhythmia lasting > 30 seconds without antiarrhythmic drugs after a 3-month blanking period (HR 1.046, 95% CI 0.54-2.01, p=0.894). Modified posterior wall ablation added to PVI did not improve 12-month arrhythmia-free survival vs PVI alone in persistent AF.
Synapse has enriched 10 related papers. Consider them for comparative context: